80 related articles for article (PubMed ID: 7483616)
1. [Magnesium or proajmaline (neogilurytmal) in treatment of recurrences of paroxysmal supraventricular tachyarrhythmias?].
Dłuzniewski M; Król J
Wiad Lek; 1994 Oct; 47(19-20):721-4. PubMed ID: 7483616
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
[TBL] [Abstract][Full Text] [Related]
3. [Antiarrhythmic effects of prajmaline (Neo-Gilurythmal) in stable angina pectoris in light of Holter electrocardiographic monitoring].
Janicki K; Orski J; Kakol J
Przegl Lek; 1995; 52(10):485-491. PubMed ID: 8834838
[TBL] [Abstract][Full Text] [Related]
4. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia.
Ballo P; Bernabò D; Faraguti SA
Eur Heart J; 2004 Aug; 25(15):1310-7. PubMed ID: 15288158
[TBL] [Abstract][Full Text] [Related]
5. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
[TBL] [Abstract][Full Text] [Related]
6. [Efficiency of antiarrhythmic drugs of class 1C and isoptin in paroxysmal supraventricular tachycardia].
Koshumbaeva KM; Tulenov MT; Belokopit IN
Klin Med (Mosk); 2002; 80(2):57-60. PubMed ID: 11898726
[TBL] [Abstract][Full Text] [Related]
7. [Experience with dl-sotalol in the treatment of supraventricular arrhythmia].
Trabulo M; Almeida M; Caires G; Mesquita A; Parreira L; Morgado F; Adragão P; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1996 Oct; 15(10):725-9, 696. PubMed ID: 9115766
[TBL] [Abstract][Full Text] [Related]
8. [Comparative effectiveness of neogilurytmal, novocainamide, etmozin, disopyramide and ethacizine in ventricular arrhythmias].
Shpektor AV; Gorshkov VA; Mamaev VI
Klin Med (Mosk); 1987 Jan; 65(1):49-52. PubMed ID: 2435956
[No Abstract] [Full Text] [Related]
9. [Comparative effectiveness of neogilurytmal, novocainamide, ethmozin, disopyramide and ethacizin in supraventricular extrasystole].
Shpektor AV; Gorshkov VA; Mamaev VI; Sherashov VS; Kurakina TI
Sov Med; 1986; (12):96-7. PubMed ID: 2436318
[No Abstract] [Full Text] [Related]
10. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Frick M; Darpö B; Ostergren J; Rosenqvist M
Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
[TBL] [Abstract][Full Text] [Related]
11. Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial.
Patten M; Maas R; Bauer P; Lüderitz B; Sonntag F; Dluzniewski M; Hatala R; Opolski G; Müller HW; Meinertz T;
Eur Heart J; 2004 Aug; 25(16):1395-404. PubMed ID: 15321697
[TBL] [Abstract][Full Text] [Related]
12. [Drug prevention of recurrence in paroxysmal and chronic atrial fibrillation].
Hindricks G; Kottkamp H; Willems S; Haverkamp W; Borggrefe M; Breithardt G
Z Kardiol; 1994; 83 Suppl 5():87-96. PubMed ID: 7846950
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intravenous adenosine in treatment of paroxysmal supraventricular tachycardia in the local population.
Seet CM
Singapore Med J; 1997 Dec; 38(12):525-8. PubMed ID: 9550919
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
Yin Y; Dalal D; Liu Z; Wu J; Liu D; Lan X; Dai Y; Su L; Ling Z; She Q; Luo K; Woo K; Dong J
Eur Heart J; 2006 Aug; 27(15):1841-6. PubMed ID: 16825288
[TBL] [Abstract][Full Text] [Related]
15. [Use of neogilurytmal in treating ventricular heart rhythm disorders].
Shpektor AV; Gorshkov VA; Mamaev VI
Kardiologiia; 1986 Sep; 26(9):103-5. PubMed ID: 2431185
[No Abstract] [Full Text] [Related]
16. Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias.
Joshi PP; Deshmukh PK; Salkar RG
J Assoc Physicians India; 1995 Aug; 43(8):529-31. PubMed ID: 8772970
[TBL] [Abstract][Full Text] [Related]
17. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia.
Gupta A; Naik A; Vora A; Lokhandwala Y
J Assoc Physicians India; 1999 Oct; 47(10):969-72. PubMed ID: 10778689
[TBL] [Abstract][Full Text] [Related]
18. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
Gambhir DS; Bhargava M; Arora R; Khalilullah M
Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
[TBL] [Abstract][Full Text] [Related]
20. Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias.
Wanless RS; Anderson K; Joy M; Joseph SP
Am Heart J; 1997 Apr; 133(4):441-6. PubMed ID: 9124166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
